|
Treatment through progression with ofranogene obadenovec (VB-111), an anti-cancer viral therapy, significantly attenuates tumor growth in recurrent GBM: Individual phase 2 patient data. |
|
|
Honoraria - Vascular Biogenics |
Consulting or Advisory Role - NanoTX; Vascular Biogenics |
Research Funding - miRNA Therapeutics (Inst); Threshold Pharmaceuticals; Vascular Biogenics |
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics |
Travel, Accommodations, Expenses - Vascular Biogenics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Agios; Novocure |
Research Funding - Agios; BioMimetix; Eisai; Genentech; Merck; VBL Therapeutics |
|
|
Consulting or Advisory Role - VBL Therapeutics |
|
|
Travel, Accommodations, Expenses - Gamida Cell; VBL Therapeutics |
|
|
No Relationships to Disclose |
|
|
Employment - VBL Therapeutics |
Stock and Other Ownership Interests - VBL Therapeutics |
Travel, Accommodations, Expenses - VBL Therapeutics |
|
|
Employment - VBL Therapeutics |
Stock and Other Ownership Interests - VBL Therapeutics |
Travel, Accommodations, Expenses - VBL Therapeutics |
|
|
Employment - VBL Therapeutics |
Leadership - VBL Therapeutics |
Stock and Other Ownership Interests - VBL Therapeutics |
Patents, Royalties, Other Intellectual Property - VBL Therapeutics |
Travel, Accommodations, Expenses - VBL Therapeutics |
|
|
Employment - VBL Therapeutics |
Leadership - VBL Therapeutics |
Stock and Other Ownership Interests - VBL Therapeutics |
Patents, Royalties, Other Intellectual Property - VBL Therapeutics |
Travel, Accommodations, Expenses - VBL Therapeutics |